Viridian Therapeutics Inc (VRDN)

Nov 18, 2024

What is HC Wainwright's Forecast for VRDN FY2024 Earnings? - MarketBeat

Nov 18, 2024

Nov 17, 2024

Viridian Therapeutics’ (VRDN) Buy Rating Reiterated at Needham & Company LLC - Defense World

Nov 17, 2024

Nov 17, 2024

Viridian Therapeutics (NASDAQ:VRDN) Price Target Raised to $34.00 - Defense World

Nov 17, 2024

Nov 16, 2024

FY2024 EPS Forecast for Viridian Therapeutics Cut by Analyst - Defense World

Nov 16, 2024

Nov 16, 2024

What is Lifesci Capital’s Estimate for VRDN FY2024 Earnings? - Defense World

Nov 16, 2024

Nov 16, 2024

What is Leerink Partnrs’ Forecast for VRDN FY2024 Earnings? - Defense World

Nov 16, 2024

Nov 15, 2024

(VRDN) Trading Signals - Stock Traders Daily

Nov 15, 2024

Nov 15, 2024

Viridian Therapeutics (NASDAQ:VRDN) Shares Down 5.8%Should You Sell? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in Viridian Ther - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Paradigm Biocapital Advisors LP Increases Stake in Viridian Ther - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Wedbush Has Pessimistic Outlook of VRDN FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

FY2024 Earnings Estimate for VRDN Issued By Leerink Partnrs - MarketBeat

Nov 15, 2024

Nov 15, 2024

What is Lifesci Capital's Estimate for VRDN FY2024 Earnings? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 15, 2024

Nov 14, 2024

Viridian Therapeutics Inc (VRDN) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Q1 Earnings Estimate for VRDN Issued By Wedbush - MarketBeat

Nov 14, 2024

Nov 14, 2024

HC Wainwright Issues Positive Forecast for Viridian Therapeutics (NASDAQ:VRDN) Stock Price - MarketBeat

Nov 14, 2024

Nov 14, 2024

Viridian Therapeutics stock target upgraded, keeps buy on veligrotug outlook By Investing.com - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 14, 2024

Nov 14, 2024

We're Not Very Worried About Viridian Therapeutics' (NASDAQ:VRDN) Cash Burn Rate - Simply Wall St

Nov 14, 2024

Nov 13, 2024

In-Depth Examination Of 11 Analyst Recommendations For Viridian Therapeutics - Benzinga

Nov 13, 2024

Nov 13, 2024

Viridian Therapeutics (NASDAQ:VRDN) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

Nov 13, 2024

Nov 12, 2024

Viridian Therapeutics Reports Increased Cash Reserves Amid Losses - TipRanks

Nov 12, 2024

Nov 12, 2024

Viridian Therapeutics Reports Third Quarter 2024 Financial Results - citybiz

Nov 12, 2024

Nov 12, 2024

Viridian Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Viridian Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - XM

Nov 12, 2024

Nov 12, 2024

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Viridian Therapeutics earnings missed by $0.09, revenue fell short of estimates - Investing.com UK

Nov 12, 2024

Nov 12, 2024

Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Viridian Therapeutics (NASDAQ:VRDN) Reaches New 1-Year HighTime to Buy? - MarketBeat

Nov 11, 2024

Nov 05, 2024

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 05, 2024

Nov 05, 2024

Viridian Therapeutics Grants 150K Stock Options to New Employees in Retention Push | VRDN Stock News - StockTitan

Nov 05, 2024

Nov 05, 2024

(VRDN) Long Term Investment Analysis - Stock Traders Daily

Nov 05, 2024

Nov 03, 2024

Net Present Value Model: Viridian Therapeutics Inc’s Veligrotug - GlobalData

Nov 03, 2024

Oct 31, 2024

Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings - Yahoo Finance

Oct 31, 2024

Oct 28, 2024

Analyst Expectations For Viridian Therapeutics's Future - Fidelity Investments

Oct 28, 2024

Oct 28, 2024

Needham & Company LLC Reaffirms Buy Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat

Oct 28, 2024

Oct 27, 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Position Boosted by Novo Holdings A S - MarketBeat

Oct 27, 2024

Oct 25, 2024

How To Trade (VRDN) - Stock Traders Daily

Oct 25, 2024

Oct 23, 2024

VRDN Factor-Based Stock Analysis - Nasdaq

Oct 23, 2024

Oct 23, 2024

Viridian Therapeutics' Superior Prospects Make It A Buy (NASDAQ:VRDN) - Seeking Alpha

Oct 23, 2024

Oct 23, 2024

Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical Results - Insider Monkey

Oct 23, 2024

Oct 22, 2024

8 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey

Oct 22, 2024

Oct 21, 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 21, 2024

Oct 19, 2024

SG Americas Securities LLC Has $374,000 Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat

Oct 19, 2024

Oct 18, 2024

State Street Corp's Strategic Reduction in Viridian Therapeutics Inc - Yahoo Finance

Oct 18, 2024

Oct 18, 2024

Viridian Therapeutics (NASDAQ:VRDN) Hits New 52-Week HighTime to Buy? - MarketBeat

Oct 18, 2024

Oct 16, 2024

Viridian Therapeutics Inc (VRDN) stock analysis: A comprehensive overview - US Post News

Oct 16, 2024

Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024

Oct 15, 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Acquired by Millennium Management LLC - MarketBeat

Oct 15, 2024

Oct 14, 2024

Financial Snapshot: Analyzing Viridian Therapeutics Inc (VRDN)’s Key Ratio Metrics - The Dwinnex

Oct 14, 2024

Oct 13, 2024

Dimensional Fund Advisors LP Purchases 97,510 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat

Oct 13, 2024

Oct 11, 2024

Viridian Therapeutics Inc [VRDN] Records 50-Day SMA of $18.29 - Knox Daily

Oct 11, 2024

Oct 11, 2024

Viridian Therapeutics (NASDAQ:VRDN) Stock Price Up 6.4%Should You Buy? - MarketBeat

Oct 11, 2024

Oct 11, 2024

Viridian Therapeutics Inc (VRDN) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Oct 11, 2024

Oct 10, 2024

The growth track for Viridian Therapeutics Inc (VRDN) has changed recently - SETE News

Oct 10, 2024

Oct 09, 2024

Stock Performance Spotlight: Viridian Therapeutics Inc (VRDN) Ends the Day at 23.40, Up by 0.60 - The Dwinnex

Oct 09, 2024